#USA #Boca Raton #KeyLift™ #Amplio Spine #Spinal Stenosis

Transforming Spine Surgery: The KeyLift™ Advantage

In a significant development for spine surgery, Amplio Spine, LLC has announced its intent to acquire the FDA-cleared KeyLift™ Expandable Interlaminar Stabilization System, which represents a groundbreaking advancement in surgical technology for spinal stenosis and degenerative disc disease. With over 100 million individuals affected by these conditions worldwide, and more than 600,000 surgeries performed annually in the U.S., the need for effective solutions is urgent.

KeyLift™: A Unique Offering

The KeyLift™ System, which includes both KeyLiftXS™ and KeyLiftXL™, stands out as the only minimally invasive option in the United States that provides two distinct platform sizes across eight SKU variants. Designed to address issues such as lumbar spinal stenosis and other non-cervical spine conditions, this system not only enhances surgical options but also simplifies the procedure for healthcare professionals.

Amplio Spine, based in Boca Raton, Florida, is positioning itself to fully commercialize this innovative platform. The company has been entirely founder-funded, which signifies a strong belief in the technology's potential without outside capital influence. The impending acquisition, which is scheduled to finalize in the second quarter of 2026, will enable Amplio Spine to expand the reach of the KeyLift™ System and cater to a broader patient base.

Proven Success and Demand

Receiving FDA 510(k) clearance in late 2023, the KeyLift™ System has already begun to show promising results, with first surgical procedures taking place in May 2024 and revenues significantly exceeding expectations even before the establishment of a dedicated sales team. This early success indicates a high level of trust and adoption among orthopedic and neurosurgical spine surgeons, as well as interventional pain physicians.

Josh Lambert, CEO and Co-Founder of Amplio Spine, emphasizes the unique advantages of the KeyLift™ System, stating, "This is not a me-too device. KeyLift™ is the only FDA-cleared expandable interlaminar stabilization system in the United States that offers both XS and XL sizing – two platforms, eight sizes, one reproducible surgical technique."

Leadership and Vision

Amplio Spine's leadership consists of industry veterans who bring a wealth of experience in spine surgery and technology. Lambert, along with COO Ryan Dickinson and CRO Blake Boesel, are committed to enhancing the operational infrastructure necessary to support the distribution and utilization of the KeyLift™ System.

Their approach combines clinical differentiation with commercial prowess. Dickinson notes, "This is the kind of platform you build a company around. KeyLift™ is clinically differentiated, IP-protected, and already adopted by surgeons. We will ensure the product, training, and customer experience meet the highest standards."

Boesel adds, "The KeyLift™ sells itself inside the OR; the surgeons who have used it already know the value it brings. What it has been missing until now is a robust commercial engine. We're poised to change that and establish a national presence for this vital technology."

Looking Ahead

The acquisition will consist of not just the KeyLiftXS™ and KeyLiftXL™ platforms but also encompass associated intellectual property, inventory, and existing customer relationships. Amplio Spine aims to build on the legacy of the late Peter Harris, a pioneer in spine technology whose vision continues to drive innovation even after his passing.

As this groundbreaking acquisition unfolds, it has the potential to markedly alter the landscape of spine surgery. Amplio Spine is not merely entering the market; it is laying the groundwork for a comprehensive response to one of the most pressing healthcare challenges faced by millions. With the combination of a unique product offering and a proficient leadership team, the KeyLift™ System is set to become a cornerstone in spinal surgery, providing hope and better outcomes for patients struggling with debilitating spine conditions.

For further information or to learn more about the KeyLift™ System, interested parties are encouraged to visit Amplio Spine's website or contact their media relations team directly.

Conclusion

As we stand on the brink of this innovative shift in spinal healthcare, the commitment exhibited by Amplio Spine signals a promising future for patients affected by spinal disorders, potentially leading to enhanced surgical techniques and improved recovery outcomes across the board.